Citicoline and DHA supplement for glaucoma patients
Part of Eyes & vision clinical trials.
This trial tests whether a dietary supplement (DHA + citicoline) can help protect vision in people with glaucoma. You may qualify if you have confirmed glaucoma in at least one eye and are between 50 and 75 years old.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have glaucoma in at least one eye, with damage seen on eye scans (OCT) and vision field tests
- You have had at least 4 reliable vision field tests before joining
- You are between 50 and 75 years old
- You have not used any vitamin or supplement in the past month
- You have not had eye surgery or laser treatment in the last 3 months
- Your vision field test score (MD) is between -3 and -20 decibels
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether NAD precursor supplements can improve nerve health and vision in people with glaucoma. If you have glaucoma with mild to moderate vision loss, this study may help understand if these supplements could protect your optic nerve.
This trial tests whether a vitamin B3 supplement called nicotinamide can help slow down vision loss in people with glaucoma. It is for those with moderate disease who are already on treatment.
This study looks at whether certain glaucoma eye drops might help protect the nerve cells in your eye over time. If you've been using the same type of eye drop for a few years, researchers will review your past eye tests to see how your vision and eye health have changed.
This study tests whether a daily vitamin B3 pill (called nicotinamide) can help protect the optic nerve and slow down vision loss in people with glaucoma. If you're already managing glaucoma with eye drops or laser, this could be an option to preserve your sight.
This study tests whether metformin can slow damage to the optic nerve in people with glaucoma. It uses eye scans and vision tests to look for changes over time, aiming to help preserve sight.
This trial studies whether nicotinamide (a form of vitamin B3/niacin) can slow or affect glaucoma progression. You may be eligible if you have newly diagnosed, untreated glaucoma or if you have treated glaucoma with measurable visual field changes.
Hear when a new Glaucoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.